Effectiveness of SMS Reminders of Blood Pressure-lowering Drugs Intake
Launched by COMENIUS UNIVERSITY · Apr 3, 2017
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
Hypertension belongs to the main risk factors of cardiovascular diseases, which are the leading cause of morbidity and mortality in the world and in the Slovak Republic. Despite the availability of effective antihypertensive treatment, blood pressure control remains a serious problem. Poor adherence to blood pressure-lowering medication is considered to be the key factor for uncontrolled blood pressure. Studies estimate the overall adherence to medication in patients with chronic diseases at around 50%. Slovak studies report even significantly lower adherence rates (15-19%), which underline...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 55 years (from the day of the 55. birthday inclusive)
- • Diagnosis of primary (essential) hypertension (I10 according to International Classification of Diseases (ICD-10))
- • Filling of blood pressure-lowering prescription(s) at trial recruitment (Visit 1)
- • Duration of antihypertensive drug treatment for at least 1 year without any discontinuation
- • Ownership of a mobile phone for personal use with the ability to open and read SMS
- • Understanding of Slovak language on native-speaker level
- • Informed consent for participation in the clinical trial and personally signed Informed Consent Form
- Exclusion Criteria:
- Exclusion criteria assessed prior to patient enrolment (by trial pharmacists):
- • Planned hospitalisation during the trial period (3 months)
- • Biological impairment affecting the ability to read the SMS (e.g. loss of vision, visual field cuts, aphasia)
- • Living in the same household with another trial participant
- • Participation in another clinical trial
- Exclusion criteria assessed after patient enrolment (by trial pharmacists and project leader):
- • Hospitalisation during the trial period
- • Patient informs he/she won't be able to participate in the trial
- • Withdrawal of Informed Consent
About Comenius University
Comenius University, established in 1919 and located in Bratislava, Slovakia, is a leading academic institution renowned for its commitment to research and education across various disciplines. As a clinical trial sponsor, the university leverages its extensive expertise in health sciences and collaborative networks to advance medical research, improve patient outcomes, and foster innovation in clinical practices. By promoting rigorous scientific methodologies and ethical standards, Comenius University aims to contribute significantly to the global body of medical knowledge while enhancing the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Banská Bystrica, , Slovakia
Banská Bystrica, , Slovakia
Bratislava, , Slovakia
Bratislava, , Slovakia
Bratislava, , Slovakia
Dubnica Nad Váhom, , Slovakia
Dubnica Nad Váhom, , Slovakia
Galanta, , Slovakia
Hnúšťa, , Slovakia
Kežmarok, , Slovakia
Liptovský Mikuláš, , Slovakia
Malacky, , Slovakia
Martin, , Slovakia
Martin, , Slovakia
Piešťany, , Slovakia
Prešov, , Slovakia
Rimavská Sobota, , Slovakia
Rožňava, , Slovakia
Spišská Nová Ves, , Slovakia
Trenčín, , Slovakia
Trenčín, , Slovakia
Vranov Nad Topľou, , Slovakia
Zvolen, , Slovakia
žilina, , Slovakia
Patients applied
Trial Officials
Zuzana Haramiova, PharmDr.
Study Director
Faculty of Pharmacy Comenius University in Bratislava, Department of Organization and Management of Pharmacy
Magdalena Kuzelova, Prof., PharmDr., PhD.
Study Chair
Faculty of Pharmacy Comenius University in Bratislava, Department of Pharmacology and Toxicology
Donald M. Morisky, Sc.D., M.S.P.H., Sc.M.
Study Chair
Fielding School of Public Health, Department of Community Health Sciences
Tomas Tesar, Doc., PharmDr., PhD, MBA
Study Chair
Faculty of Pharmacy Comenius University in Bratislava, Department of Organization and Management of Pharmacy
Michal Stasko, PharmDr.
Study Chair
Faculty of Pharmacy Comenius University in Bratislava, Department of Organization and Management of Pharmacy
Martin Hulin, Ing., Mgr., PhD.
Study Chair
Research Institute for Child Psychology and Pathopsychology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials